Discover how Professor Shabir Madhi is advancing maternal vaccines to safeguard newborns from RSV, GBS, and more.

Newborns are at risk for serious complications from influenza infections but are not eligible for vaccination until they are ...

Maternal flu vaccination was associated with a reduced risk of influenza infection during infants' first 6 months of life, an ...

A group of mothers in Victoria say they've experienced trouble accessing the jab for a highly infectious illness that infects ...

While respiratory syncytial virus (RSV) typically causes mild symptoms in adults, the virus can be life-threatening for infants. The seasonal virus is the most common cause of lower respiratory tract ...

In fact, the CDC found that "maternal vaccination is the best proection against COVID-19 for pregnant women and infants less ...

India has reduced the percentage of zero-dose children from 0.11% in 2023 to 0.06% in 2024, setting a global immunization ...

Recent vaccination announcements have led to some confusion. Four physicians weigh in on who should get vaccinated and when ...

A groundbreaking vaccine administered to two elephants at the Cincinnati Zoo & Botanical Garden appears to be effective, a ...

Conclusion While maternal vaccine trials pose unique challenges, they are not insurmountable. Careful planning and execution by researchers can overcome these challenges throughout the trial process.

FDA's New Vaccine Policy: How Flawed Reasoning Threatens Public Health in the Name of Scientific Rigor ...

Shares of Moderna MRNA rose nearly 6% yesterday after the U.S. Centers for Disease Control and Prevention (“CDC”) adopted new ...